2016
DOI: 10.1111/irv.12393
|View full text |Cite
|
Sign up to set email alerts
|

Influenza activity in Kenya, 2007–2013: timing, association with climatic factors, and implications for vaccination campaigns

Abstract: BackgroundInformation on the timing of influenza circulation remains scarce in Tropical regions of Africa.ObjectivesWe assessed the relationship between influenza activity and several meteorological factors (temperature, specific humidity, precipitation) and characterized the timing of influenza circulation and its implications to vaccination strategies in Kenya.MethodsWe analyzed virologically confirmed influenza data for outpatient influenza‐like illness (ILI), hospitalized for severe acute respiratory infec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
40
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(41 citation statements)
references
References 19 publications
1
40
0
Order By: Relevance
“…Some of the pathogens were uncommon, and it is likely that a seasonal peak of some viruses fell outside the study period. In this location, peak occurrence of influenza (A or B) is in the second half of each year based on inpatient pediatric surveillance [17,18]. HMPV circulated prior to the start of RSV season, as shown from corresponding hospital data ( Supplementary Figure 1), unlike previous studies reporting co-circulation with RSV [19].…”
Section: Discussionmentioning
confidence: 84%
“…Some of the pathogens were uncommon, and it is likely that a seasonal peak of some viruses fell outside the study period. In this location, peak occurrence of influenza (A or B) is in the second half of each year based on inpatient pediatric surveillance [17,18]. HMPV circulated prior to the start of RSV season, as shown from corresponding hospital data ( Supplementary Figure 1), unlike previous studies reporting co-circulation with RSV [19].…”
Section: Discussionmentioning
confidence: 84%
“…Where E(Yt) is the expected weekly con rmed in uenza cases every ten thousand outpatient visits on week t; α is the intercept; cb( ) represents the cross-basis matrix of climate factors, including mean temperature, relative humidity, aggregate rainfall, wind speed and sunshine; df is the degree of freedom; X j is the other explanatory variables of meteorological factors; time refers to duration of seasonality and long-term trend; holiday is an indicator variable which equals to 1 if week t is in school holidays and 0 otherwise. We used Akaike Information criterion (AIC) to choose the df, which was supported by other references [10][11][12][13] . The weeks of lag structure in the models were determined by incubation period and infectious period of in uenza virus 14 , the Akaike Information criteria and other references 10,11 .…”
Section: A Poisson Regression With a Quasi-poisson Function Was Estabmentioning
confidence: 88%
“…We used Akaike Information criterion (AIC) to choose the df, which was supported by other references [10][11][12][13] . The weeks of lag structure in the models were determined by incubation period and infectious period of in uenza virus 14 , the Akaike Information criteria and other references 10,11 . We provided all AICs in the appendix (Supplementary Tab.…”
Section: A Poisson Regression With a Quasi-poisson Function Was Estabmentioning
confidence: 88%
See 1 more Smart Citation
“…Between 2014 and 2017, DSLP provided laboratory support for two observational rotavirus vaccine studies: Rotavirus-Vaccine Impact on Diarrhea in Africa (R-VIDA), a multi-country study that includes Kenya, Mali and Gambia; and Rotavirus Immunization Program Evaluation in Kenya ((RIPEK), a multi-site study within Kenya) to determine the effectiveness of the rotavirus vaccine. Recent influenza studies in Kenya that were supported by DLSP assisted in describing influenza disease burden in the country which was crucial information used by the Kenyan National Immunization Technical Advisory Group (KENITAG) for the recommendation of influenza vaccination for children ages 6-23 months [13][14][15]. In addition, this diagnostic capacity enabled other complex clinical research projects including Pediatric Respiratory Etiology Surveillance Study (PRESS) and Child Health and Mortality Prevention Surveillance (CHAMPS) that collect data to describe the causes of under-five child mortality in high-mortality settings [16].…”
Section: Determining Burden Of Disease and Monitoring Disease Intervementioning
confidence: 99%